The standard schedule is a starting point, not a requirement
As covered in our guide on how titration schedules work, the standard step-up timeline for GLP-1 medications reflects what works for most people — not a fixed rule that applies uniformly. Slowing down titration, meaning staying at a given dose step longer than the standard schedule before increasing, is a common, clinically supported adjustment rather than a deviation from proper treatment.
Common reasons to slow down
- GI side effects that haven't settled by the time the next increase is due. If nausea, vomiting, or other symptoms covered in our GI side effects overview are still significant rather than easing, extending the current dose step gives your body more time to adjust before adding more.
- A pattern of side effects intensifying with each increase, suggesting you may be a slower responder to dose changes than the standard schedule assumes.
- Other health factors — a concurrent illness, a demanding period at work or in life where managing more intense side effects would be especially difficult, or other individual circumstances your prescriber factors into pacing.
- A deliberate choice, particularly relevant if you're pursuing a body recomposition goal rather than maximum-speed weight loss, where a more gradual pace can better match what your nutrition and training plan can support.
How this conversation typically goes
Raise it proactively rather than waiting to be asked — if your next scheduled increase is approaching and you're still dealing with significant side effects from the current dose, tell your prescriber directly rather than assuming you have to follow the standard calendar. See our guide on talking to your doctor about side effects that aren't improving for how to describe your symptoms effectively.
What this doesn't mean
Slowing titration isn't the same as stopping it — it's a pacing adjustment, not an indication that GLP-1 treatment isn't right for you. Most people who extend a dose step do eventually continue titrating, just on a timeline that better matches their individual tolerance.
The bottom line
The standard titration schedule is a reasonable default, not a fixed requirement — extending a dose step when side effects haven't settled is a normal, clinically supported adjustment, and worth raising proactively with your prescriber rather than pushing through on the standard calendar regardless of how you're feeling.